GB828847A
(en)
|
1956-12-14 |
1960-02-24 |
Ilford Ltd |
Improvements in or relating to cyanine dyes
|
FR1242962A
(fr)
|
1959-08-25 |
1960-10-07 |
Kodak Pathe |
Nouveau procédé pour la préparation de colorants sensibilisateurs de la série des cyanines et des mérocyanines et produits obtenus
|
GB1268773A
(en)
|
1968-03-15 |
1972-03-29 |
Glaxo Lab Ltd |
NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
GB1429184A
(en)
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
US4044126A
(en)
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
USRE28819E
(en)
|
1972-12-08 |
1976-05-18 |
Syntex (U.S.A.) Inc. |
Dialkylated glycol compositions and medicament preparations containing same
|
DE2844606A1
(de)
|
1978-10-13 |
1980-04-24 |
Bayer Ag |
Heterocyclische farbstoffe
|
GB2013703B
(en)
*
|
1978-01-25 |
1982-06-03 |
Bayer Ag |
Heterocyclic dyestuffs
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
US4358603A
(en)
|
1981-04-16 |
1982-11-09 |
Syntex (U.S.A.) Inc. |
Acetal stabilized prostaglandin compositions
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
GB9222253D0
(en)
*
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
GB9304920D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
PT836605E
(pt)
*
|
1995-07-06 |
2002-07-31 |
Novartis Ag |
Pirrolopirimidinas e processos para a sua preparacao
|
US7119174B2
(en)
|
1995-12-18 |
2006-10-10 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
US6716575B2
(en)
*
|
1995-12-18 |
2004-04-06 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
US5962312A
(en)
|
1995-12-18 |
1999-10-05 |
Sugen, Inc. |
Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
|
GB9707800D0
(en)
|
1996-05-06 |
1997-06-04 |
Zeneca Ltd |
Chemical compounds
|
DE69722220T2
(de)
*
|
1996-08-09 |
2004-02-19 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
4-substituierte beta-carboline als immunomodulatoren
|
GB9622363D0
(en)
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9625184D0
(en)
*
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6057329A
(en)
|
1996-12-23 |
2000-05-02 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6759212B1
(en)
*
|
1997-08-15 |
2004-07-06 |
Chugai Seiyaku Kabushiki Kaisha |
Cell cycle-regulating proteins
|
US6294532B1
(en)
|
1997-08-22 |
2001-09-25 |
Zeneca Limited |
Oxindolylquinazoline derivatives as angiogenesis inhibitors
|
US7462605B2
(en)
*
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
US6143480A
(en)
|
1998-09-03 |
2000-11-07 |
Fuji Photo Film Co., Ltd. |
Leuco dye and image recording medium containing the same
|
US6706491B1
(en)
*
|
1999-04-09 |
2004-03-16 |
The Board Of Trustees Of The University Of Illinois |
Reagents and methods for identifying and modulating expression of genes regulated by p21
|
US20050113460A1
(en)
*
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US6982265B1
(en)
|
1999-05-21 |
2006-01-03 |
Bristol Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
EP1203013A4
(de)
|
1999-07-21 |
2004-10-13 |
Univ Massachusetts |
Kinasehemmende polypeptide und ihre anwendung
|
WO2001014378A1
(fr)
|
1999-08-23 |
2001-03-01 |
Shionogi & Co., Ltd. |
DERIVES DE PYRROLOTRIAZINE A ACTIVITES INHIBANT sPLA¿2?
|
WO2001021594A1
(en)
|
1999-09-21 |
2001-03-29 |
Astrazeneca Ab |
Quinazoline compounds and pharmaceutical compositions containing them
|
GB9922173D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
BR0014116A
(pt)
|
1999-09-21 |
2002-05-21 |
Astrazeneca Ab |
Uso de um composto, composto, métodos para preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
ES2306671T3
(es)
|
1999-10-07 |
2008-11-16 |
Amgen Inc. |
Inhibidores de triazina quinasa.
|
US6455525B1
(en)
|
1999-11-04 |
2002-09-24 |
Cephalon, Inc. |
Heterocyclic substituted pyrazolones
|
SK288019B6
(sk)
*
|
1999-12-24 |
2012-11-05 |
Aventis Pharma Limited |
Azaindoles derivatives, their use and pharmaceutical composition containing thereof
|
JP2003520855A
(ja)
*
|
2000-01-28 |
2003-07-08 |
アストラゼネカ アクチボラグ |
化学的化合物
|
AU782878B2
(en)
*
|
2000-02-05 |
2005-09-08 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of erk
|
TR200103787T1
(tr)
|
2000-02-05 |
2002-10-21 |
Vertex Pharmaceuticals Incorporated |
Hücre-dışı sinyal ayarlı kinazların(ERK) inhibitörü olarak yararlı pirazol bileşimler
|
EP1134221A1
(de)
|
2000-03-15 |
2001-09-19 |
Aventis Pharma Deutschland GmbH |
Substituierte beta-Carboline als lkB-Kinasehemmer
|
AU3741801A
(en)
*
|
2000-03-15 |
2001-09-24 |
Aventis Pharma Gmbh |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
EP1209158A1
(de)
|
2000-11-18 |
2002-05-29 |
Aventis Pharma Deutschland GmbH |
Substitutierte beta-Carboline
|
JP2001294772A
(ja)
|
2000-04-10 |
2001-10-23 |
Fuji Photo Film Co Ltd |
着色組成物、インクジェット用インク及びインクジェット記録方法
|
JP2001302667A
(ja)
*
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
US6555329B2
(en)
*
|
2000-06-09 |
2003-04-29 |
Boehringer Ingelheim International Gmbh |
Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
|
US6335342B1
(en)
|
2000-06-19 |
2002-01-01 |
Pharmacia & Upjohn S.P.A. |
Azaindole derivatives, process for their preparation, and their use as antitumor agents
|
PL360439A1
(en)
|
2000-06-28 |
2004-09-06 |
Astrazeneca Ab |
Substituted quinazoline derivatives and their use as inhibitors
|
AU2002222933A1
(en)
|
2000-07-13 |
2002-01-30 |
Millennium Pharamaceuticals, Inc. |
Inhibitors of factor xa
|
US20050009876A1
(en)
*
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
PL213199B1
(pl)
|
2000-08-10 |
2013-01-31 |
Pharmacia Italia Spa |
Zwiazek bicyklo-pirazolowy, sposób wytwarzania go, jego kompozycja farmaceutyczna, oraz kombinatoryczna biblioteka chemiczna
|
US6352858B1
(en)
*
|
2000-09-11 |
2002-03-05 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of BTAK expression
|
US6613776B2
(en)
*
|
2000-09-15 |
2003-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6638926B2
(en)
|
2000-09-15 |
2003-10-28 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6610677B2
(en)
*
|
2000-09-15 |
2003-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6660731B2
(en)
*
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6455559B1
(en)
|
2001-07-19 |
2002-09-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
|
WO2002048114A1
(en)
|
2000-11-27 |
2002-06-20 |
Pharmacia Italia S.P.A. |
Phenylacetamido- pyrazole derivatives and their use as antitumor agents
|
EE200300247A
(et)
|
2000-11-28 |
2003-10-15 |
Pfizer Products Inc. |
Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena
|
FR2818278B1
(fr)
|
2000-12-20 |
2003-02-28 |
Sod Conseils Rech Applic |
Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
|
US20040048849A1
(en)
*
|
2000-12-20 |
2004-03-11 |
Gregoire Prevost |
Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
|
CN100436452C
(zh)
|
2000-12-21 |
2008-11-26 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的吡唑化合物
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
MY130778A
(en)
|
2001-02-09 |
2007-07-31 |
Vertex Pharma |
Heterocyclic inhibitiors of erk2 and uses thereof
|
US6864255B2
(en)
|
2001-04-11 |
2005-03-08 |
Amgen Inc. |
Substituted triazinyl amide derivatives and methods of use
|
GEP20053712B
(en)
*
|
2001-05-14 |
2005-12-26 |
Pfizer Prod Inc |
Tartrate Salts of 5,8,14-Triazatetracyclo {10.3.1.0²,11.04,9}-Hexadeca-2(11),3,5,7,9-Pentaene and Pharmaceutical Compositions Thereof
|
KR20040000507A
(ko)
*
|
2001-05-24 |
2004-01-03 |
야마노우치세이야쿠 가부시키가이샤 |
3-퀴놀린-2(1h)-일리덴인돌린-2-온 유도체
|
WO2002096867A2
(en)
|
2001-05-30 |
2002-12-05 |
Lg Biomedical Institute |
Inhibitors of protein kinase for the treatment of disease
|
US6762179B2
(en)
*
|
2001-05-31 |
2004-07-13 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinase
|
ATE339418T1
(de)
*
|
2001-06-01 |
2006-10-15 |
Vertex Pharma |
Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
AU2002318367B2
(en)
|
2001-06-22 |
2006-09-28 |
The Procter & Gamble Company |
Fabric care compositions for lipophilic fluid systems
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
JP2004534857A
(ja)
|
2001-07-19 |
2004-11-18 |
フアルマシア・イタリア・エツセ・ピー・アー |
フェニルアセトアミド−チアゾール誘導体、それらの製造のための方法及び抗癌剤としてのそれらの使用
|
WO2003009852A1
(en)
|
2001-07-24 |
2003-02-06 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6872533B2
(en)
*
|
2001-07-27 |
2005-03-29 |
The Regents Of The University Of California |
STK15 (STK6) gene polymorphism and methods of determining cancer risk
|
US6916798B2
(en)
*
|
2001-08-03 |
2005-07-12 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of GSK-3 and uses thereof
|
CZ2004168A3
(cs)
*
|
2001-08-06 |
2004-05-12 |
Pharmaciaáitaliaás@P@A |
Aminoizoxazolové derivátyŹ účinné jako kinázové inhibitoryŹ způsob jejich přípravy a farmaceutické prostředkyŹ které je obsahují
|
US20030073692A1
(en)
*
|
2001-08-07 |
2003-04-17 |
Pharmacia & Upjohn S.P.A. |
Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
|
US6927293B2
(en)
|
2001-08-30 |
2005-08-09 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6806272B2
(en)
*
|
2001-09-04 |
2004-10-19 |
Boehringer Ingelheim Pharma Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
EP1444207A2
(de)
|
2001-09-19 |
2004-08-11 |
Pharmacia Corporation |
Substituierte pyrazolylverbindungen zur behandlung von entzündungen
|
BR0212613A
(pt)
*
|
2001-09-19 |
2004-08-31 |
Pharmacia Corp |
Compostos de indazol substituìdos para o tratamento de inflamação
|
WO2003027075A2
(en)
*
|
2001-09-19 |
2003-04-03 |
Pharmacia Corporation |
Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
|
BR0212617A
(pt)
*
|
2001-09-19 |
2005-02-09 |
Pharmacia Corp |
Compostos de pirazolila substituìdo para o tratamento de inflamação
|
JP4542338B2
(ja)
|
2001-09-26 |
2010-09-15 |
ファイザー イタリア ソシエタ ア レスポンサビリタ リミタータ |
キナーゼ阻害因子として活性なアミノインダゾール誘導体、それらの製造方法及びそれらを含有する医薬組成物
|
GB0124299D0
(en)
|
2001-10-10 |
2001-11-28 |
Astrazeneca Ab |
Crystal structure of enzyme and uses thereof
|
CA2463989C
(en)
|
2001-10-17 |
2012-01-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
|
US20040010027A1
(en)
*
|
2001-12-17 |
2004-01-15 |
Pharmacia & Upjohn Spa |
Hydroxphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical comositions comprising them
|
SE0104340D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New compounds
|
ATE446093T1
(de)
*
|
2001-12-24 |
2009-11-15 |
Astrazeneca Ab |
Substituierte chinazolin-derivate als aurora- kinase inhibitoren
|
EA008379B1
(ru)
|
2002-02-01 |
2007-04-27 |
Ариад Джин Терапьютикс, Инк. |
Фосфорсодержащие соединения и их применения
|
FR2836914B1
(fr)
|
2002-03-11 |
2008-03-14 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
AU2003225800A1
(en)
*
|
2002-03-15 |
2003-09-29 |
Hayley Binch |
Azolylaminoazine as inhibitors of protein kinases
|
ES2289279T3
(es)
*
|
2002-03-15 |
2008-02-01 |
Vertex Pharmaceuticals Incorporated |
Composiciones utiles como inhibidores de proteinquinasas.
|
EP1485380B1
(de)
*
|
2002-03-15 |
2010-05-19 |
Vertex Pharmaceuticals Incorporated |
Azolylaminoazine als proteinkinasehemmer
|
ATE466580T1
(de)
*
|
2002-03-15 |
2010-05-15 |
Vertex Pharma |
Azolylaminoazine als proteinkinasehemmer
|
SE0200979D0
(sv)
|
2002-03-28 |
2002-03-28 |
Astrazeneca Ab |
New compounds
|
AU2003230802B2
(en)
|
2002-04-08 |
2007-08-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
WO2003087395A2
(en)
|
2002-04-15 |
2003-10-23 |
Inserm |
Methods to identify anti-tumoral agents inhibiting rasgap / aurora kinase interactions
|
WO2003091246A1
(en)
|
2002-04-26 |
2003-11-06 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
ES2340475T3
(es)
|
2002-05-01 |
2010-06-04 |
Vertex Pharmaceuticals Incorporated |
Estructura cristalizada de proteina aurora-2 y sus bolsillos de union.
|
EP1506176B1
(de)
|
2002-05-17 |
2013-04-24 |
Pfizer Italia S.r.l. |
Als kinase-hemmer wirksame aminoindazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
|
US20050239780A1
(en)
*
|
2002-05-31 |
2005-10-27 |
Akira Suga |
Tetrahydropyran derivative
|
US6989451B2
(en)
*
|
2002-06-04 |
2006-01-24 |
Valeant Research & Development |
Heterocyclic compounds and uses thereof
|
FR2840905B1
(fr)
|
2002-06-12 |
2006-07-07 |
Centre Nat Rech Scient |
Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers
|
AU2002311176A1
(en)
|
2002-06-12 |
2003-12-31 |
Axia Biosciences, Inc. |
Chfr protein-catalyzed polyubiquitination of aurora kinase a and aurora kinase b
|
JP4463679B2
(ja)
|
2002-06-14 |
2010-05-19 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
US7361665B2
(en)
*
|
2002-07-09 |
2008-04-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
|
AU2003253880A1
(en)
|
2002-07-15 |
2004-02-02 |
Sugen, Inc. |
Novel kinases
|
DE60320560T2
(de)
|
2002-07-17 |
2008-12-11 |
Pfizer Italia S.R.L. |
Heterobicyclische pyrazolderivate als kinaseinhibitoren
|
MXPA05000945A
(es)
|
2002-07-25 |
2005-05-16 |
Pharmacia Italia Spa |
Biciclo-pirazoles activos como inhibidores de la cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
|
US20060100233A1
(en)
|
2002-07-25 |
2006-05-11 |
Manuela Villa |
Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
AU2003250040A1
(en)
|
2002-07-25 |
2004-02-23 |
Pharmacia Italia S.P.A |
Condensed heterocyclic pyrazole derivatives as kinase inhibitors
|
BR0313397A
(pt)
*
|
2002-08-14 |
2005-06-28 |
Vertex Pharmaceuticals Incorpo |
Inibidores de proteina cinase e usos destes
|
KR20050057520A
(ko)
*
|
2002-09-23 |
2005-06-16 |
쉐링 코포레이션 |
사이클린 의존성 키나제 억제제로서의 이미다조피라진
|
US20040157804A1
(en)
|
2002-10-16 |
2004-08-12 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
US7262200B2
(en)
|
2002-10-25 |
2007-08-28 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
US20040102360A1
(en)
*
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
US6909001B2
(en)
|
2002-12-12 |
2005-06-21 |
Pharmacia Corporation |
Method of making tricyclic aminocyanopyridine compounds
|
UA81790C2
(uk)
|
2002-12-19 |
2008-02-11 |
Фармация Италия С.П.А. |
Заміщені піролопіразольні похідні як інгібітори кінази
|
AU2003292435A1
(en)
|
2002-12-23 |
2004-07-14 |
Astrazeneca Ab |
4- (pyridin-4-ylamino) -quinazoline derivatives as anti-tumor agents
|
ATE412657T1
(de)
|
2002-12-24 |
2008-11-15 |
Astrazeneca Ab |
Therapeutische quinazolin-derivate
|
DE60315892T2
(de)
|
2002-12-24 |
2008-08-14 |
Astrazeneca Ab |
Phosphonooxy-chinazolin derivate und ihre pharmazeutische verwendung
|
AU2003290322A1
(en)
|
2002-12-24 |
2004-07-22 |
Astrazeneca Ab |
Quinazoline compounds
|
CL2004000016A1
(es)
|
2003-01-21 |
2005-04-15 |
Wyeth Corp |
Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina.
|
DE602004022633D1
(de)
|
2003-01-30 |
2009-10-01 |
Boehringer Ingelheim Pharma |
2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
|
WO2004070062A2
(en)
|
2003-02-04 |
2004-08-19 |
Wyeth |
Compositions and methods for diagnosing and treating cancers
|
EP1592389B1
(de)
|
2003-02-14 |
2009-04-22 |
Laboratoires Serono SA |
Derivate von piperazine-2-carboxamide
|
BRPI0407544A
(pt)
|
2003-02-17 |
2006-02-14 |
Pharmacia Italia Spa |
derivados de pirazol tetracìclicos como inibidores da cinase, processo para a sua preparação e composições farmacêuticas que os compreendem
|
US6861422B2
(en)
*
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
CA2517020C
(en)
|
2003-02-26 |
2012-06-26 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, method for the production and use thereof in the form of drugs
|
WO2006018628A1
(en)
|
2003-03-07 |
2006-02-23 |
Astrazeneca Ab |
Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer
|
BRPI0408486A
(pt)
|
2003-03-11 |
2006-04-04 |
Pharmacia Italia Spa |
derivados de biciclopirazol ativos como inibidores da cinase, processo para a sua preparação e composições farmacêuticas compreendendo-os
|
ATE450530T1
(de)
|
2003-03-13 |
2009-12-15 |
Vertex Pharma |
Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
|
JP2006521398A
(ja)
|
2003-03-28 |
2006-09-21 |
サイオス・インコーポレーテツド |
TGFβの二−環式ピリミジン阻害剤
|
US20070179161A1
(en)
|
2003-03-31 |
2007-08-02 |
Vernalis (Cambridge) Limited. |
Pyrazolopyrimidine compounds and their use in medicine
|
WO2004090106A2
(en)
|
2003-04-04 |
2004-10-21 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
|
BRPI0409263A
(pt)
*
|
2003-04-09 |
2006-03-28 |
Millennium Pharm Inc |
composto; composição farmacêutica; método para tratar uma doença mediada por ikk e método para inibir ikk em um paciente que dele necessita
|
PT1620429E
(pt)
*
|
2003-04-11 |
2009-04-28 |
Glenmark Pharmaceuticals Sa |
Novos compostos heterocíclicos úteis para o tratamento de perturbações inflamatórias e alérgicas: processo para a sua preparação e composições farmacêuticas que os contêm
|
RU2005135337A
(ru)
|
2003-04-16 |
2006-06-10 |
Астразенека Аб (Se) |
Производные хиназолина для лечения злокачественного новообразования
|
WO2004096129A2
(en)
|
2003-04-24 |
2004-11-11 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
JP4616831B2
(ja)
|
2003-04-24 |
2011-01-19 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Akt活性の阻害剤
|
EP1631548B1
(de)
|
2003-04-24 |
2009-10-28 |
Merck & Co., Inc. |
Hemmer der akt aktivität
|
WO2004096130A2
(en)
|
2003-04-24 |
2004-11-11 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
US20040242559A1
(en)
|
2003-04-25 |
2004-12-02 |
Aventis Pharma S.A. |
Novel indole derivatives, preparation thereof as medicinal products and pharmaceutical compositions, and especially as KDR inhibitors
|
WO2005004988A2
(en)
|
2003-05-01 |
2005-01-20 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
EP1620108B1
(de)
|
2003-05-01 |
2012-06-06 |
Bristol-Myers Squibb Company |
Pyrazol-amine-verbindungen als kinase-hemmer
|
US20050125852A1
(en)
|
2003-05-09 |
2005-06-09 |
Sugen, Inc. |
Novel kinases
|
RS52899B
(en)
|
2003-05-22 |
2014-02-28 |
Nerviano Medical Sciences S.R.L. |
PIRAZOLO-HINAZOLINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS
|
US7345046B2
(en)
*
|
2003-05-30 |
2008-03-18 |
Chiron Corporation |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents
|
DE602004015108D1
(de)
|
2003-06-02 |
2008-08-28 |
Astrazeneca Ab |
(3-((chinazolin-4-yl)amino)-1h-pyrazol-1-yl)acetamid derivate und verwandte verbindungen als aurora kinase inhibitoren zur behandlung von proliferativen erkrankungen wie krebs
|
TW200505452A
(en)
|
2003-06-17 |
2005-02-16 |
Astrazeneca Ab |
Chemical compounds
|
EP1636225B1
(de)
*
|
2003-06-20 |
2010-02-24 |
Novartis Vaccines and Diagnostics, Inc. |
Pyridino¬1,2-a pyrimidin-4-onverbindungen als mittel gegen krebs
|
US20050065171A1
(en)
*
|
2003-06-25 |
2005-03-24 |
Shakespeare William C. |
Substituted purine derivatives
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
ES2322707T3
(es)
|
2003-07-03 |
2009-06-25 |
Euro-Celtique S.A. |
Derivados de 2-piridina alquino utiles para tratar el dolor.
|
US20060178318A1
(en)
|
2003-07-03 |
2006-08-10 |
Shubha Anand |
Use of aurora kinase inhibitors for reducing the resistance of cancer cells
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
GB0315966D0
(en)
|
2003-07-08 |
2003-08-13 |
Cyclacel Ltd |
Compounds
|
US20050032869A1
(en)
|
2003-07-08 |
2005-02-10 |
Pharmacia Italia S.P.A. |
Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
US7141568B2
(en)
|
2003-07-09 |
2006-11-28 |
Pfizer Italia S.R.L. |
Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
WO2005016252A2
(en)
|
2003-07-11 |
2005-02-24 |
Ariad Gene Therapeutics, Inc. |
Phosphorus-containing macrocycles
|
EA010109B1
(ru)
|
2003-07-16 |
2008-06-30 |
Янссен Фармацевтика Н.В. |
Триазолопиримидиновые производные в качестве ингибиторов киназы-3 гликогенсинтазы
|
EP1781659B1
(de)
|
2003-07-16 |
2008-11-05 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidin derivate als inhibitoren von glycogen synthase kinase-3
|
US7589232B2
(en)
|
2003-07-21 |
2009-09-15 |
Laboratories Serono S.A. |
Alkynyl aryl carboxamides
|
US20050101623A1
(en)
*
|
2003-07-23 |
2005-05-12 |
Pharmacia Corporation |
Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
|
DK1648878T3
(da)
|
2003-07-24 |
2009-08-10 |
Euro Celtique Sa |
Piperidinforbindelser og farmaceutiske sammensætninger, som indeholder dem
|
US7619059B2
(en)
|
2003-07-29 |
2009-11-17 |
Life Technologies Corporation |
Bimolecular optical probes
|
US20050026984A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
CA2533870A1
(en)
|
2003-07-30 |
2005-02-10 |
Shudong Wang |
Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
|
BRPI0412347A
(pt)
|
2003-07-30 |
2006-09-05 |
Cyclacel Ltd |
2-aminofenil-4-fenilpiridinas como inibidores de quinase
|
US7094791B2
(en)
*
|
2003-07-31 |
2006-08-22 |
Avalon Pharmaceuticals, Inc. |
Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
|
US20050043346A1
(en)
*
|
2003-08-08 |
2005-02-24 |
Pharmacia Italia S.P.A. |
Pyridylpyrrole derivatives active as kinase inhibitors
|
US7279575B2
(en)
*
|
2003-08-08 |
2007-10-09 |
Pfizer Italia S.R.L. |
Pyrimidylpyrrole derivatives active as kinase inhibitors
|
AU2004267094A1
(en)
*
|
2003-08-20 |
2005-03-03 |
Vertex Pharmaceuticals Incorporated |
(4 -amino -1,2, 5-oxadiazol-4-yl) -hetxiroaromatic compounds useful as protein kinase inhibitors
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
AU2004272306A1
(en)
|
2003-09-12 |
2005-03-24 |
Merck Serono Sa |
Benzimidazole acetonitriles
|
ATE395346T1
(de)
|
2003-09-16 |
2008-05-15 |
Astrazeneca Ab |
Chinazolinderivate als tyrosinkinaseinhibitoren
|
AU2004272345A1
(en)
|
2003-09-16 |
2005-03-24 |
Astrazeneca Ab |
Quinazoline derivatives
|
EP1667996B1
(de)
|
2003-09-16 |
2009-07-22 |
Astrazeneca AB |
Chinazolinderivate
|
AU2004274013A1
(en)
|
2003-09-17 |
2005-03-31 |
Icos Corporation |
Use of Chk1 inhibitors to control cell proliferation
|
AU2003270848A1
(en)
|
2003-09-17 |
2005-04-27 |
Sunesis Pharmaceuticals, Inc. |
Identification of kinase inhibitors
|
WO2005028478A1
(en)
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
US20050085531A1
(en)
*
|
2003-10-03 |
2005-04-21 |
Hodge Carl N. |
Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
SI1678166T1
(sl)
|
2003-10-14 |
2009-10-31 |
Univ Arizona State |
Inhibitorji proteinske kinaze
|
ES2284054T3
(es)
|
2003-10-14 |
2007-11-01 |
Pharmacia Corporation |
Compuestos de pirazinona sustituidos para el tratamiento de la inflamacion.
|
KR20060123164A
(ko)
|
2003-10-17 |
2006-12-01 |
아스트라제네카 아베 |
암 치료에 사용하기 위한 4-(피라졸-3-일아미노)피리미딘유도체
|
JP5164380B2
(ja)
|
2003-10-21 |
2013-03-21 |
サイクラセル リミテッド |
ピリミジン−4−イル−3,4−チオン化合物及び治療におけるその使用
|
WO2005037797A1
(en)
|
2003-10-21 |
2005-04-28 |
Pharmacia Corporation |
Substituted pyrazole urea compounds for the treatment of inflammation
|
WO2005040133A1
(en)
|
2003-10-23 |
2005-05-06 |
Pharmacia Corporation |
Pyrimidine compounds for the treatment of inflammation
|
WO2005044270A1
(en)
|
2003-11-04 |
2005-05-19 |
4Sc Ag |
Oxadiazolopyrazine derivatives as pharmaceutically active compounds
|
CA2545942C
(en)
|
2003-11-14 |
2012-07-10 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
CA2546360A1
(en)
*
|
2003-11-19 |
2005-06-09 |
Signal Pharmaceuticals, Llc |
Methods of treating diseases and disorders by targeting multiple kinases
|
FR2864084B1
(fr)
|
2003-12-17 |
2006-02-10 |
Aventis Pharma Sa |
Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
|
CA2547703A1
(en)
|
2003-12-17 |
2005-07-28 |
Sgx Pharmaceuticals, Inc. |
Bicyclic pyrazolo-fused compounds as protein kinase modulators
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
WO2005071419A2
(en)
|
2004-01-16 |
2005-08-04 |
Ipsogen |
Protein expression profiling and breast cancer prognosis
|
CN1910183A
(zh)
|
2004-01-23 |
2007-02-07 |
希龙公司 |
四氢咔啉化合物作为抗癌药
|
TW200526204A
(en)
|
2004-02-03 |
2005-08-16 |
Pharmacia Italia Spa |
1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
|
FR2865934B1
(fr)
|
2004-02-05 |
2006-05-05 |
Sanofi Synthelabo |
Utilisation de derives d'indolizine 1,2,3 substitues, inhibiteurs des fgfs, pour la preparation de medicaments utiles pour le traitement de maladies liees a une angiogenese pathologique choroidienne
|
GB0402653D0
(en)
|
2004-02-06 |
2004-03-10 |
Cyclacel Ltd |
Compounds
|
AR047969A1
(es)
|
2004-02-25 |
2006-03-15 |
Schering Corp |
Pirazolotriazinas como inhibidores de quinasa
|
CA2560954A1
(en)
|
2004-03-26 |
2005-10-20 |
Amphora Discovery Corporation |
Certain triazole-based compounds, compositions, and uses thereof
|
BRPI0509580A
(pt)
|
2004-03-30 |
2007-11-27 |
Pfizer Prod Inc |
combinações de inibidores de transdução de sinal
|
CA2560454C
(en)
|
2004-03-30 |
2013-05-21 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of jak and other protein kinases
|
FR2868421B1
(fr)
|
2004-04-01 |
2008-08-01 |
Aventis Pharma Sa |
Nouveaux benzothiazoles et leur utilisation comme medicaments
|
CA2563699C
(en)
|
2004-04-23 |
2014-03-25 |
Exelixis, Inc. |
Kinase modulators and method of use
|
EP1763524A1
(de)
|
2004-04-23 |
2007-03-21 |
Takeda San Diego, Inc. |
Indolderivate und deren verwendung als kinaseinhibitoren
|
TW200538453A
(en)
|
2004-04-26 |
2005-12-01 |
Bristol Myers Squibb Co |
Bicyclic heterocycles as kinase inhibitors
|
WO2005105777A1
(en)
|
2004-05-05 |
2005-11-10 |
Pharmacia & Upjohn Company Llc |
Substituted thiophene amide compounds for the treatment of inflammation
|
AU2005245386B2
(en)
|
2004-05-07 |
2008-11-27 |
Amgen Inc. |
Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
|
PT1905773E
(pt)
|
2004-05-14 |
2012-10-25 |
Millennium Pharm Inc |
Compostos e métodos para inibir a progressão mitótica por inibição da quinase aurora
|
WO2005118544A2
(en)
|
2004-05-18 |
2005-12-15 |
Rigel Pharmaceuticals, Inc. |
Cycloalkyl substituted pyrimidinediamine compounds and their uses
|
EP1598343A1
(de)
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
JPWO2005113550A1
(ja)
|
2004-05-20 |
2008-03-27 |
三菱ウェルファーマ株式会社 |
アミノピリミジン誘導体及びその医薬としての用途
|
BRPI0511433A
(pt)
|
2004-05-21 |
2007-12-11 |
Chiron Corp |
derivados de quinolina substituìda como inibidores de cinesina mitótica
|
US20080318803A1
(en)
|
2004-05-27 |
2008-12-25 |
Vertex Pharmaceuticals |
Biomarkers for Monitoring Impdh Pathway Inhibition
|
JP2008501628A
(ja)
|
2004-06-02 |
2008-01-24 |
武田薬品工業株式会社 |
インドール誘導体およびがんの治療用途
|
CA2569277A1
(en)
|
2004-06-04 |
2005-12-15 |
Pfizer Products Inc. |
Method for treating abnormal cell growth
|
EP1781293A1
(de)
|
2004-06-04 |
2007-05-09 |
Amphora Discovery Corporation |
Verbindungen auf chinolin- und isochinolin-basis mit atp-verwendender enzymhemmender aktivität und zusammensetzungen und verwendungen daraus
|
FR2871158A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
JP2008502687A
(ja)
|
2004-06-14 |
2008-01-31 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
CN101001845A
(zh)
|
2004-06-15 |
2007-07-18 |
阿斯利康(瑞典)有限公司 |
作为抗癌药物的取代喹唑酮
|
JP4836280B2
(ja)
|
2004-06-18 |
2011-12-14 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
癌を治療するためのキネシンスピンドルタンパク質(ksp)阻害剤としてのn−(1−(1−ベンジル−4−フェニル−1h−イミダゾール−2−イル)−2,2−ジメチルプロピル)ベンズアミド誘導体および関連化合物
|
DE102004029784A1
(de)
*
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
RU2007102226A
(ru)
|
2004-06-23 |
2008-07-27 |
Айрм Ллк (Bm) |
Соединения и композиции в качестве ингибиторов протеинкиназы
|
WO2006000589A1
(de)
|
2004-06-28 |
2006-01-05 |
Altana Pharma Ag |
Novel pyrimidines
|
US7253167B2
(en)
|
2004-06-30 |
2007-08-07 |
Bristol-Myers Squibb Company |
Tricyclic-heteroaryl compounds useful as kinase inhibitors
|
US7553838B2
(en)
|
2004-07-01 |
2009-06-30 |
Merck & Co. Inc. |
Mitotic kinesin inhibitors
|
WO2006007496A2
(en)
|
2004-07-01 |
2006-01-19 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
EP1781653A1
(de)
|
2004-07-05 |
2007-05-09 |
Astex Therapeutics Limited |
3,4-disubstituierte pyrazole als inhibitoren von cyclinabhängigen kinasen (cdk) oder aurora-kinase oder glycogen-synthase-3 (gsk-3)
|
US7601714B2
(en)
|
2004-07-08 |
2009-10-13 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pyrimidine derivatives useful as inhibitors of PKC-theta
|
CA2573380A1
(en)
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Amide derivatives as inhibitors of histone deacetylase
|
EP1768955A1
(de)
|
2004-07-12 |
2007-04-04 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Amidderivate als histondeacetylase-hemmer
|
EP1768984B1
(de)
|
2004-07-16 |
2010-10-20 |
Sunesis Pharmaceuticals, Inc. |
Als aurora-kinase-inhibitoren nutzbare thienopyrimidine
|
DE102004034623A1
(de)
*
|
2004-07-16 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US20080261821A1
(en)
|
2004-07-21 |
2008-10-23 |
The Regents Of Te University Of California |
Mechanism-Based Crosslinkers
|
WO2006008545A2
(en)
|
2004-07-22 |
2006-01-26 |
Astex Therapeutics Limited |
Thiazole and isothiazole derivatives as protein kinase inhibitors
|
EP1773830A1
(de)
|
2004-07-22 |
2007-04-18 |
AstraZeneca AB |
Für die behandlung und prävention von krebs geeignete kondensierte pyrimidone
|
EP2264033A1
(de)
|
2004-07-27 |
2010-12-22 |
SGX Pharmaceuticals, Inc. |
3,5-DIPHENYL-SUBSTITUIERTE PYRROLO[2,3b]PYRIDIN-DERIVATE ZUR VERWENDUNG ALS KINASE INHIBITOREN
|
EP1782315A4
(de)
|
2004-07-30 |
2009-06-24 |
Rosetta Inpharmatics Llc |
Prognose für brustkrebspatienten
|
CA2575808A1
(en)
|
2004-08-02 |
2006-02-16 |
Osi Pharmaceuticals, Inc. |
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
|
WO2006017549A2
(en)
|
2004-08-03 |
2006-02-16 |
Vertex Pharmaceuticals Incoporated |
Cell-based kinase assay
|
WO2006023083A1
(en)
|
2004-08-12 |
2006-03-02 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
WO2006020767A2
(en)
|
2004-08-13 |
2006-02-23 |
Genentech, Inc. |
Thiazole based inhibitors of atp-utilizing enzymes
|
AU2005277587A1
(en)
|
2004-08-18 |
2006-03-02 |
Merck Sharp & Dohme Corp. |
Mitotic kinesin inhibitors
|
WO2006031348A2
(en)
|
2004-08-18 |
2006-03-23 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
JP2008510734A
(ja)
|
2004-08-18 |
2008-04-10 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
JP2008510823A
(ja)
|
2004-08-23 |
2008-04-10 |
メルク エンド カムパニー インコーポレーテッド |
Akt活性阻害剤
|
CA2575804A1
(en)
*
|
2004-08-26 |
2006-03-02 |
Boehringer Ingelheim International Gmbh |
Pteridinones used as plk (polo like kinase) inhibitors
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
WO2006021548A1
(de)
|
2004-08-27 |
2006-03-02 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
US20070207996A1
(en)
|
2004-08-30 |
2007-09-06 |
Auger Kurt R |
Novel Compositions And Methods Of Treatment
|
GB0419416D0
(en)
|
2004-09-01 |
2004-10-06 |
Inst Of Ex Botany Ascr |
4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
|
WO2006024836A1
(en)
|
2004-09-01 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as b-raf inhibitors
|
AR050926A1
(es)
|
2004-09-03 |
2006-12-06 |
Astrazeneca Ab |
Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac)
|
JP2008514628A
(ja)
|
2004-09-24 |
2008-05-08 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
蛋白質キナーゼ類のイミダゾ{4,5−b}ピラジノン阻害剤
|
AR050948A1
(es)
|
2004-09-24 |
2006-12-06 |
Hoffmann La Roche |
Derivados de ftalazinona; su obtencion y su utilizacion en la fabricacion de medicamentos para el tratamiento del cancer.
|
US20060069101A1
(en)
|
2004-09-27 |
2006-03-30 |
Kim Kyoung S |
Prodrugs of protein tyrosine kinase inhibitors
|
US20060079494A1
(en)
|
2004-09-27 |
2006-04-13 |
Santi Daniel V |
Specific kinase inhibitors
|
US7459448B2
(en)
|
2004-10-04 |
2008-12-02 |
Millennium Pharmaceuticals, Inc. |
Lactam compounds useful as protein kinase inhibitors
|
FR2876377B1
(fr)
|
2004-10-11 |
2007-03-16 |
Univ Claude Bernard Lyon |
Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
|
JP4237242B2
(ja)
|
2004-10-12 |
2009-03-11 |
アストラゼネカ アクチボラグ |
キナゾリン誘導体
|
US20080207616A1
(en)
|
2004-10-15 |
2008-08-28 |
Astrazeneca Ab |
Quinoxalines as B Baf Inhhibitors
|
WO2006050076A1
(en)
|
2004-10-29 |
2006-05-11 |
Janssen Pharmaceutica, N.V. |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
EP1813609B1
(de)
|
2004-10-29 |
2013-06-19 |
Msd K.K. |
Neue aminopyridinderivate mit selektiva aurora-a-hemmender wirkung
|
CA2587894A1
(en)
|
2004-11-22 |
2006-06-01 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
GB0427917D0
(en)
|
2004-12-21 |
2005-01-26 |
Astrazeneca Ab |
Chemical compounds
|
ITPI20040099A1
(it)
|
2004-12-24 |
2005-03-24 |
Maurizio Pacini |
Sistema di realizzazione di tappeto erboso mediante micro-plantule preradicate
|
WO2006070192A1
(en)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Thiazole and isothiazole derivatives that modulate the acivity of cdk, gsk and aurora kynases
|
JP5507049B2
(ja)
|
2004-12-30 |
2014-05-28 |
アステックス、セラピューティックス、リミテッド |
医薬品
|
EP1836188A1
(de)
|
2004-12-30 |
2007-09-26 |
Astex Therapeutics Limited |
Die aktivität von cdk, gsk und aurora-kinasen modullierende pyrazolderivate
|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
GB0504475D0
(en)
|
2005-03-04 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
GB0504474D0
(en)
|
2005-03-04 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
FR2882751B1
(fr)
|
2005-03-04 |
2007-09-14 |
Aventis Pharma Sa |
Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, procede de preparation, compositions les contenant et utilisation
|
FR2884821B1
(fr)
|
2005-04-26 |
2007-07-06 |
Aventis Pharma Sa |
Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
GB0509223D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
GB0509224D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of intracellular enzymatic activity
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
JP2008542433A
(ja)
*
|
2005-06-09 |
2008-11-27 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
CDK−1インヒビターとしてのα−カルボリン
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
EP2049535A1
(de)
*
|
2006-08-02 |
2009-04-22 |
Takeda Pharmaceutical Company Limited |
Alpha-carbolinderivate und verfahren zu ihrer herstellung
|
EP2079696A2
(de)
|
2006-10-09 |
2009-07-22 |
Takeda San Diego, Inc. |
Kinase-inhibitoren
|
WO2008045834A2
(en)
|
2006-10-09 |
2008-04-17 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
EP2223925A1
(de)
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase-Inhibitoren
|
US20100120717A1
(en)
*
|
2006-10-09 |
2010-05-13 |
Brown Jason W |
Kinase inhibitors
|
WO2009129401A1
(en)
*
|
2008-04-16 |
2009-10-22 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|